Surgery Doctors in Phila., PA Accepting Medicare
1 Surgery doctors found. Showing 1 - 1
 Dr. David Marvin Sokol, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 854 S. Swanson St., Phila., PA 19147 Phone: 215-462-8889 |
News Archive
Seat of emotion in the brain critical for creating long-term memories
When we suddenly get the answer to a riddle or understand the solution to a problem, we can practically feel the light bulb click on in our head. But what happens after the 'Aha!' moment? Why do the things we learn through sudden insight tend to stick in our memory?
First patient enrolled in CSL Behring's rVIIa-FP Phase II/III study to treat patients with hemophilia A or B with inhibitors
CSL Behring announced today that the first patient has been enrolled in its Phase II/III clinical study evaluating the pharmacokinetics (PK), efficacy, and safety of the company's recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) for on-demand treatment in patients with congenital hemophilia A or B who have developed an inhibitor to factor VIII or factor IX replacement therapy.
CPSC announces grant awards to prevent pool and spa drownings, drain entrapments
U.S. Consumer Product Safety Commission Chairman Elliot F. Kaye and U.S. Rep. Debbie Wasserman Schultz (FL-23) announced today the awardees of a first-of-its-kind grant program aimed at preventing pool and spa drownings and drain entrapments. Five local governments will receive more than $780,000 in Pool Safely Grant Program (PSGP) funds.
Phase 1 BelCHOP study shows belinostat and CHOP chemo regimen as first-line treatment for PTCL
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations and a primary focus in Hematology and Oncology, and Onxeo S.A., an innovative company specializing in the development of orphan oncology drugs, today jointly announced the results from their Phase 1 combination trial of belinostat (Beleodaq) with the CHOP (Cyclophosphamide, Hydroxyl-doxorubicin; Vincristine, and Prednisone) chemotherapy regimen as first-line treatment for newly diagnosed peripheral T-cell lymphoma (PTCL).
Largest description of ST3GAL5 deficiency combined using data from 104 individuals
Researchers have combined the largest description of ST3GAL5 deficiency using detailed natural history data from 104 individuals of Amish ancestry born between 1986 and 2017 with a definite or probable diagnosis of ST3GAL5 deficiency.
› Verified 9 days ago